A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19
Clinical trial NCT05035576 · TERMINATED
Trial details
- NCT number
- NCT05035576
- Sponsor
- Optinose US Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2021-11-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.